Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees

Showing results (31-40 of 376) with videos related to

Pageof 38
Sort By:
Antimicrobial Agents and Chemotherapy|November 15, 2011
Determination of meropenem penetration into the lung from Sparse dataMartin G Kees, Thomas P Lodise, G L Drusano
Lancet (London, England)|September 2, 2017
Very low LDL-cholesterol concentrations achieved: which target is next?G Kees Hovingh, S Matthijs Boekholdt, Erik S Stroes
European Journal of Preventive Cardiology|November 23, 2019
PCSK9 as predictor for recurrent cardiovascular disease in familial hypercholesterolemiaLaurens F Reeskamp, Tycho R Tromp, G Kees Hovingh
The Journal of Antimicrobial Chemotherapy|July 7, 2011
Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patientsMartin G Kees, Susanne Weber, Frieder Kees, et al.
Journal of the American College of Cardiology|May 23, 2020
Familial Hypercholesterolemia: The Most Common Monogenic Disorder in HumansJohn J P Kastelein, Laurens F Reeskamp, G Kees Hovingh
Expert Opinion on Investigational Drugs|May 1, 2020
Gene-based therapy in lipid management: the winding road from promise to practiceTycho R Tromp, Erik S G Stroes, G Kees Hovingh
European Heart Journal|October 12, 2017
Homozygous familial hypercholesterolaemia: light at the end of the tunnelRobert M Stoekenbroek, G Kees Hovingh, John J P Kastelein
Nature Reviews. Endocrinology|October 28, 2018
Inhibiting PCSK9 - biology beyond LDL controlRobert M Stoekenbroek, Gilles Lambert, Bertrand Cariou, et al.
Journal of the American College of Cardiology|April 25, 2020
Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus SeminarDavid Preiss, Jonathan A Tobert, G Kees Hovingh, et al.
European Heart Journal|April 27, 2017
Can we afford not to screen for FH?Robert M Stoekenbroek, John J P Kastelein, G Kees Hovingh
Pageof 38

Showing results (31-40 of 376) with videos related to

Sort By:
Pageof 38
Antimicrobial Agents and Chemotherapy|November 15, 2011
Determination of meropenem penetration into the lung from Sparse dataMartin G Kees, Thomas P Lodise, G L Drusano
Lancet (London, England)|September 2, 2017
Very low LDL-cholesterol concentrations achieved: which target is next?G Kees Hovingh, S Matthijs Boekholdt, Erik S Stroes
European Journal of Preventive Cardiology|November 23, 2019
PCSK9 as predictor for recurrent cardiovascular disease in familial hypercholesterolemiaLaurens F Reeskamp, Tycho R Tromp, G Kees Hovingh
The Journal of Antimicrobial Chemotherapy|July 7, 2011
Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patientsMartin G Kees, Susanne Weber, Frieder Kees, et al.
Journal of the American College of Cardiology|May 23, 2020
Familial Hypercholesterolemia: The Most Common Monogenic Disorder in HumansJohn J P Kastelein, Laurens F Reeskamp, G Kees Hovingh
Expert Opinion on Investigational Drugs|May 1, 2020
Gene-based therapy in lipid management: the winding road from promise to practiceTycho R Tromp, Erik S G Stroes, G Kees Hovingh
European Heart Journal|October 12, 2017
Homozygous familial hypercholesterolaemia: light at the end of the tunnelRobert M Stoekenbroek, G Kees Hovingh, John J P Kastelein
Nature Reviews. Endocrinology|October 28, 2018
Inhibiting PCSK9 - biology beyond LDL controlRobert M Stoekenbroek, Gilles Lambert, Bertrand Cariou, et al.
Journal of the American College of Cardiology|April 25, 2020
Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus SeminarDavid Preiss, Jonathan A Tobert, G Kees Hovingh, et al.
European Heart Journal|April 27, 2017
Can we afford not to screen for FH?Robert M Stoekenbroek, John J P Kastelein, G Kees Hovingh
Pageof 38